Darghk




Lux in tenebris



Improbable botanicals.

Made possible.


NON-GMO BY DESIGN · NOVEL BY OUTCOME · PROPRIETARY BY NATURE



VECTORLESS MUTAGENESIS
EXEMPT-STATUS CULTIVARS
TRAIT DISCOVERY-AS-A-SERVICE TDaaS



TECHNOLOGY



A new path for

botanical novelty


The Darghk Protocol accelerates plant trait development using only a species' own genomic architecture. No foreign DNA. No vectors. No transgenic liability. What emerges is genuinely unprecedented — cultivars that could not have existed through conventional breeding, arriving on a timeline that conventional breeding could never match.


The process is proprietary. The outcomes are documented. The regulatory position is clean.



01 Genomic induction

Non-mediated physical induction initiates structural rearrangement within the native genome — no external sequence introduced at any stage.



02 Stochastic mutagenesis

Controlled mutagenic parameters drive domain shuffling and trait variance at rates exceeding conventional selection by orders of magnitude.



03 Iterative selection

Each generation is banked, evaluated, and selected against defined phenotypic targets. The loop runs until the Apex line is isolated.



04 Biological stabilization

Advanced lines are developed toward reproductive isolation or fertility — genetic stabilization that simultaneously functions as competitive protection or broad dispersal.





WHY IT MATTERS



Biotech outcomes without
biotech burdens



Transgenic pipelines carry permanent regulatory drag, labeling exposure, and market access friction that cannot be engineered away. The Darghk Protocol delivers equivalent trait acceleration with none of that overhead — because the resulting cultivars are, by every applicable standard, non-GMO.


100%
NON-GMO

Compliant Under all current US federal standards including USDA, FDA, and Non-GMO Project criteria.
4 AGENCIES. ZERO FLAGS.

USDA APHIS, NIH, FDA, and EPA frameworks each expressly exclude this protocol from their oversight mechanisms.
NO FOREIGN DNA INTRODUCED

Every genomic change is derived exclusively from the species' own library. Entirely.



ACCESS MODELS



Three ways to access
Darghk technology


Material, Extract, & Oil

Proprietary materials, essential oils, and botanical extracts derived exclusively from Darghk-line cultivars. A unique scent or flavor profile available from a single source.

PERFUME HOUSES · F&B BRANDS · FUNCTIONAL INGREDIENTS
Genetics Licensing

Darghk genetics licensed to vertical farming and CEA operators under per-unit royalty agreements. Lines optimized for controlled-environment performance or characteristics.

INDOOR AG · CEA OPERATORS · SEED COMPANIES
Trait Discovery

The Darghk protocol as a service. Clients supply a phenotypic problem or germplasm to explore and Darghk delivers the Apex germplasm(S). Process parameters remain entirely proprietary.


PER ENGAGEMENT FEE STRUCTURE · PER-UNIT ROYALTY



REGULATORY POSITION



Unregulated
by design



The protocol's regulatory position is not the result of a loophole, a petition, or a discretionary waiver. It reflects the documented, intended scope of each applicable federal framework. A private self-determination memorandum is maintained for every engagement.



USDA APHIS · 7 CFR §340



Unregulated



No foreign DNA. No plant pest vectors. Confirmed per AIR FAQ guidance.



NIH · Recombinant DNA



Not applicable



No vectors. No recombinant constructs. Outside the definitional scope of NIH recombinant DNA oversight.



FDA · GRAS / HOSU



Compliant



Parent species carry established history of safe use. No novel allergens or toxins introduced.



EPA · FIFRA / PIP



Not applicable



No plant-incorporated protectant produced. Pesticidal application is not the intent.





CONTACT



Something
unprecedented
is growing.



Industry inquiries, partnership discussions, and CRO engagement requests welcomed.


Darghk is selective by design.


Request access or inquiry.








SEND


Darghk




Lux in tenebris

© 2025 Darghk. All Rights Reserved. |
Privacy Policy |
Terms and Conditions